DealBook: U.S. Drug Maker AbbVie Increases Bid for Shire, as Cost of Moving Abroad Rises

AbbVie said that it had increased its bid to acquire the Irish drug maker that had rejected its previous takeover offer. The new bid is about $51.6 billion.